Natural killer cells for antiviral therapy

Davey M. Smith, Jolie R. Schafer, Brian Tullius, Laura Witkam, Silke Paust

Open source

DOI
10.1126/scitranslmed.abl5278
Published
2023-01-04
Container
Science Translational Medicine
Publisher
American Association for the Advancement of Science (AAAS)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1126/scitranslmed.abl5278,
  title = {Natural killer cells for antiviral therapy},
  author = {Davey M. Smith and Jolie R. Schafer and Brian Tullius and Laura Witkam and Silke Paust},
  year = {2023},
  journal = {Science Translational Medicine},
  doi = {10.1126/scitranslmed.abl5278},
  url = {https://doi.org/10.1126/scitranslmed.abl5278}
}

RIS

TY  - JOUR
TI  - Natural killer cells for antiviral therapy
AU  - Davey M. Smith
AU  - Jolie R. Schafer
AU  - Brian Tullius
AU  - Laura Witkam
AU  - Silke Paust
PY  - 2023
JO  - Science Translational Medicine
DO  - 10.1126/scitranslmed.abl5278
UR  - https://doi.org/10.1126/scitranslmed.abl5278
ER  - 

APA

Smith, D. M., Schafer, J. R., Tullius, B., Witkam, L., & Paust, S. (2023). Natural killer cells for antiviral therapy. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.abl5278

Source records